BioScrip (BIOS) Misses Q2 EPS by 5c

August 8, 2016 6:54 AM EDT

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

BioScrip (NASDAQ: BIOS) reported Q2 EPS of ($0.14), $0.05 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $232.5 million versus the consensus estimate of $229.58 million.


BioScrip sees FY2016 EPS of ($0.48)-($0.38).

For earnings history and earnings-related data on BioScrip (BIOS) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment